TABLE 1.

Estimated Absorbed Dose After Intravenous Administration of ⁶⁸Ga-RM26

Target organ	Mean	SD
Adrenals	7.48E–03	2.71E–03
Brain	1.25E–03	4.08E–04
Breasts	4.56E–03	2.41E–03
Gallbladder wall	8.00E–03	2.67E–03
Lower large intestine wall	1.74E–02	3.64E–03
Small intestine	1.04E–02	2.84E–03
Stomach wall	7.51E–03	2.83E–03
Upper large intestine wall	9.44E–03	3.06E–03
Heart wall	5.93E–03	2.78E–03
Kidneys	3.60E–02	1.89E–03
Liver	1.59E–02	2.43E–03
Lungs	6.01E–03	1.01E–03
Muscle	7.76E–03	1.19E–03
Ovaries	2.06E–02
Pancreas	2.25E–01	3.77E–02
Red marrow	9.15E–03	1.88E–03
Osteogenic cells	1.04E–02	4.07E–03
Skin	5.16E–03	2.17E–03
Spleen	1.93E–02	1.41E–03
Testes	1.09E–02	6.08E–04
Thymus	5.07E–03	2.60E–03
Thyroid	4.73E–03	2.42E–03
Urinary bladder wall	1.09E+00	2.25E–01
Uterus	3.55E–02
Total body	9.98E–03	2.51E–03
Effective dose equivalent	9.12E–02	1.40E–02
Effective dose	6.57E–02	1.24E–02

Data are mSv/MBq, n = 5, 3 men and 2 women.